| P50 | author | Natalya Zhuravskaya | Q87880350 |
| | Irina Kuzina | Q88246433 |
| P2093 | author name string | Alexandra Lobodenko | |
| | Kirill Vladimirovich Kosilov | |
| | Olga Shakirova | |
| | Sergey Loparev | |
| P2860 | cites work | Economic burden of urgency urinary incontinence in the United States: a systematic review | Q26864020 |
| | Discontinuation Rates of Anticholinergic Medications Used for the Treatment of Lower Urinary Tract Symptoms | Q29301765 |
| | Adherence, persistence and switch rates for anticholinergic drugs used for overactive bladder in women: data from the Norwegian Prescription Database | Q30647619 |
| | Randomized controlled trial of cyclic and continuous therapy with trospium and solifenacin combination for severe overactive bladder in elderly patients with regard to patient compliance | Q34536721 |
| | Overactive bladder symptom severity is associated with falls in community-dwelling adults: LOHAS study. | Q36821714 |
| | Factors affecting therapeutic compliance: A review from the patient's perspective | Q36822915 |
| | The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis | Q37206637 |
| | A review of adherence to drug therapy in patients with overactive bladder | Q37212314 |
| | Update on the management of overactive bladder: patient considerations and adherence | Q37283704 |
| | Impact of invasive bladder cancer and orthotopic urinary diversion on general health-related quality of life: An SF-36 survey | Q37561011 |
| | Safety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladder | Q37914849 |
| | A review of anticholinergic medications for overactive bladder symptoms | Q38117169 |
| | Long-term adherence to antimuscarinic therapy in everyday practice: a systematic review | Q38154045 |
| | Persistence and adherence with urinary antispasmodic medications among employees and the impact of adherence on costs and absenteeism | Q42686232 |
| | Overactive bladder medication adherence when medication is free to patients. | Q43186899 |
| | Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects | Q44791344 |
| | The relative importance of health related quality of life and prescription insurance coverage in the decision to pharmacologically manage symptoms of overactive bladder | Q44933030 |
| | Additional correction of OAB symptoms by two anti-muscarinics for men over 50 years old with residual symptoms of moderate prostatic obstruction after treatment with Tamsulosin | Q45039160 |
| | Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the california medicaid program | Q46301443 |
| | The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial/ethnic group and age: results from OAB-POLL. | Q46934879 |
| | An overactive bladder symptom and health-related quality of life short-form: validation of the OAB-q SF. | Q48045519 |
| | Psychometric performance of the incontinence quality-of-life questionnaire among patients with overactive bladder and urinary incontinence. | Q48229039 |
| | Employees with overactive bladder: work loss burden. | Q50761314 |
| | Long-term patterns of use and treatment failure with anticholinergic agents for overactive bladder. | Q51197694 |
| | Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. | Q53315918 |
| | Bladder diary volume per void measurements in detrusor overactivity | Q79329985 |
| | Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage | Q79924820 |
| | Patient-reported reasons for discontinuing overactive bladder medication | Q84898899 |
| | Predictors of discontinuing overactive bladder medications | Q84898904 |
| | What is the value of medication adherence? | Q88159970 |
| P433 | issue | 4 | |
| P304 | page(s) | 239-248 | |
| P577 | publication date | 2016-06-03 | |
| P1433 | published in | Therapeutic advances in urology | Q26842184 |
| P1476 | title | Treatment compliance of working persons to high-dose antimuscarinic therapies: a randomized trial | |
| P478 | volume | 8 | |